Reduced Reverse Cholesterol Transport Efficacy in Healthy Men with Undesirable Postprandial Triglyceride Response

Postprandial Hypertriglyceridaemia Revisited In The Era Of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement

(2019) Genovefa D. Kolovou et al.   Current Vascular Pharmacology

Levels of prebeta-1 high-density lipoprotein are elevated in 3 phenotypes of dyslipidemia

(2018) Eveline Oestreicher Stock et al.   Journal of Clinical Lipidology

2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2019

(2018)   DIABETES CARE

Association of Serum Cholesterol Efflux Capacity With Mortality in Patients With ST-Segment Elevation Myocardial Infarction

(2018) Maryse Guerin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease

(2018) A.David Marais   PATHOLOGY

HDL structure and function is profoundly affected when stored frozen in the absence of cryoprotectants

(2017) Michael Holzer et al.   JOURNAL OF LIPID RESEARCH

Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease

(2016) Børge G. Nordestgaard   CIRCULATION RESEARCH

Association of Cholesterol Efflux Capacity With Clinical Features of Metabolic Syndrome: Relevance to Atherosclerosis

(2016) Julie Gall et al.   Journal of the American Heart Association

Triglycerides and cardiovascular disease

(2014) Børge G Nordestgaard et al.   LANCET

Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetes

(2014) Hussein N. Yassine et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Endogenous CETP activity as a predictor of cardiovascular risk: Determination of the optimal range

(2013) Elise F. Villard et al.   ATHEROSCLEROSIS

Functionality of postprandial larger HDL2 particles is enhanced following CETP inhibition therapy

(2012) Natacha Bellanger et al.   ATHEROSCLEROSIS

Cholesterol Efflux and Metabolic Abnormalities Associated With Low High-Density-Lipoprotein-Cholesterol and High Triglycerides in Statin-Treated Coronary Men With Low-Density Lipoprotein-Cholesterol

(2011) Rosalinda Posadas-Sánchez et al.   AMERICAN JOURNAL OF CARDIOLOGY

Atheroprotective Reverse Cholesterol Transport Pathway Is Defective in Familial Hypercholesterolemia

(2011) Natacha Bellanger et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Postprandial lipoprotein metabolism: VLDL vs chylomicrons

(2011) Katsuyuki Nakajima et al.   CLINICA CHIMICA ACTA

Assessment and Clinical Relevance of Non-Fasting and Postprandial Triglycerides: An Expert Panel Statement

(2011) Genovefa D. Kolovou et al.   Current Vascular Pharmacology

Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

(2011) Amit V. Khera et al.   NEW ENGLAND JOURNAL OF MEDICINE

Torcetrapib Differentially Modulates the Biological Activities of HDL2 and HDL3 Particles in the Reverse Cholesterol Transport Pathway

(2008) Giovanna Catalano et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Enhanced removal of cholesterol from macrophage foam cells to serum from type IV hypertriglyceridemic subjects

(2007) Nesrine Attia et al.   ATHEROSCLEROSIS